Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.860
-0.240 (-11.43%)
At close: Feb 11, 2026, 4:00 PM EST
1.800
-0.060 (-3.23%)
After-hours: Feb 11, 2026, 7:17 PM EST
Serina Therapeutics Revenue
Serina Therapeutics had revenue of $116.00K in the twelve months ending September 30, 2025, down -96.33% year-over-year. In the year 2024, Serina Therapeutics had annual revenue of $56.00K, down -98.22%.
Revenue (ttm)
$116.00K
Revenue Growth
-96.33%
P/S Ratio
177.47
Revenue / Employee
$8,923
Employees
13
Market Cap
20.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.00K | -3.10M | -98.22% |
| Dec 31, 2023 | 3.15M | 3.12M | 9,173.53% |
| Dec 31, 2022 | 34.00K | -110.00K | -76.39% |
| Dec 31, 2021 | 144.00K | -217.00K | -60.11% |
| Dec 31, 2020 | 361.00K | -1.37M | -79.11% |
| Dec 31, 2019 | 1.73M | 332.00K | 23.78% |
| Dec 31, 2018 | 1.40M | -8.00K | -0.57% |
| Dec 31, 2017 | 1.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSER News
- 8 days ago - Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event - GlobeNewsWire
- 14 days ago - Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson's disease - GlobeNewsWire
- 27 days ago - Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity - GlobeNewsWire
- 2 months ago - Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry - GlobeNewsWire
- 2 months ago - Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program - GlobeNewsWire
- 3 months ago - Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewsWire
- 3 months ago - Serina Therapeutics Provides Regulatory Update on SER-252 Program - GlobeNewsWire
- 4 months ago - Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors - GlobeNewsWire